Naturally occurring antibodies to cholesterol: a new theory of LDL cholesterol metabolism (Q33702152)

28 July 2017

1 reference

title

Naturally occurring antibodies to cholesterol: a new theory of LDL cholesterol metabolism (English)

1 reference

28 July 2017

Alving CR

1

1 reference

28 July 2017

Wassef NM

series ordinal

2

1 reference

28 July 2017

publication date

1 August 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

20

1 reference

28 July 2017

issue

8

1 reference

28 July 2017

page(s)

362-366

1 reference

A receptor-mediated pathway for cholesterol homeostasis

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Management of primary hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Cholesterol management in theory and practice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Heart attacks: gone with the century?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Atherosclerosis: The low-density lipoprotein receptor hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Antibodies to cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Analysis of anticholesterol antibodies using hydrophobic membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Antibodies to cholesterol: biological implications of antibodies to lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Naturally occurring autoantibodies to cholesterol in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Cholesterol sulphate-reactive autoantibodies are specifically increased in chronic chagasic human patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Immunoglobulin as the major low density lipoprotein binding protein in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Posttransplant hyperlipidemia: the treatment dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

Hyperlipidemia in renal transplant recipients: natural history and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901496-6

7 January 2021

10.1016/S0167-5699(99)01496-6

Identifiers

DOI

1 reference

28 July 2017

1 reference